Skip to main content
Top
Published in: Rheumatology International 4/2003

01-07-2003 | Original Article

Joint pain and arthritis in renal transplant recipients and correlation with cyclosporine therapy

Authors: Hamide Kart-Köseoglu, A. E. Yücel, I. Isıklar, I. Türker, Z. Akçalı, M. Haberal

Published in: Rheumatology International | Issue 4/2003

Login to get access

Abstract

Objective

The aim of this study was to determine the prevalence of joint pain and arthritis in renal transplant recipients and to investigate relationships with various laboratory and clinical parameters.

Methods

Eighty-two patients who underwent renal transplantation (RT) had joint examinations and reportedv by questionnaire on levels of joint pain and arthritis. Each individual was then followed by the rheumatology department for 1 year, with joint examination and laboratory tests every 3 months.

Results

Thirty-one of 82 patients (37.8%) complained of joint pain before RT, of whom seven reported pain continuing after the operation. Seventeen of the 82 (20.7%) began to suffer joint pain after RT. Six (7.3%) and three (3.7%) of the 82 patients, respectively, developed arthritis before and after transplantation.

Conclusion

The study showed that joint pain is common before and after RT. In renal transplant recipients, joint pain significantly correlated with serum cyclosporine levels higher than 200 ng/ml.
Literature
1.
go back to reference Kessler BM, Netter P, Azoulay E, Mayeux D, Pere P, Gaucher A (1992) Dialysis-associated arthropathy: a multicentre survey of 171 patients receiving haemodialysis for over 10 years. Br J Rheumatol 31:157–162PubMed Kessler BM, Netter P, Azoulay E, Mayeux D, Pere P, Gaucher A (1992) Dialysis-associated arthropathy: a multicentre survey of 171 patients receiving haemodialysis for over 10 years. Br J Rheumatol 31:157–162PubMed
2.
go back to reference Bardin T, Lebail-Darne JL, Zingraff J, Laredo JD, Voisin MC, Kreis H et al (1995) Dialysis arthropathy: outcome after renal transplantation. Am J Med 99:243–248CrossRefPubMed Bardin T, Lebail-Darne JL, Zingraff J, Laredo JD, Voisin MC, Kreis H et al (1995) Dialysis arthropathy: outcome after renal transplantation. Am J Med 99:243–248CrossRefPubMed
3.
go back to reference Marcen R, Gallego N, Orofino L, Gamez C, Estepa MR, Sabater J et al (1995) Impairment of tubular secretion of urate in renal transplant patients on cyclosporine. Nephron 70:307–313PubMed Marcen R, Gallego N, Orofino L, Gamez C, Estepa MR, Sabater J et al (1995) Impairment of tubular secretion of urate in renal transplant patients on cyclosporine. Nephron 70:307–313PubMed
4.
go back to reference Carlini RG, Rojas E, Arminio A, Weisinger JR, Bellorin-Font E (1998) What are the bone lesions in patients with more than four years of a functioning renal transplant? Nephrol Dial Transplant 13:103–104CrossRef Carlini RG, Rojas E, Arminio A, Weisinger JR, Bellorin-Font E (1998) What are the bone lesions in patients with more than four years of a functioning renal transplant? Nephrol Dial Transplant 13:103–104CrossRef
5.
go back to reference Bailie GR, Eisele G (1990) Cyclosporine-associated arthralgia. Clin Nephrol 33:256–257PubMed Bailie GR, Eisele G (1990) Cyclosporine-associated arthralgia. Clin Nephrol 33:256–257PubMed
6.
go back to reference Dubost JJ, Fourcade J, Sourbrier M, Ristori JM, Sauvezie B, Deteix P (1997) Epiphyseal pain from cyclosporine in renal transplants. Nephrologie 18:22 Dubost JJ, Fourcade J, Sourbrier M, Ristori JM, Sauvezie B, Deteix P (1997) Epiphyseal pain from cyclosporine in renal transplants. Nephrologie 18:22
7.
go back to reference Torregrosa JV, Campistol JM, Montesinos M, Fenollosa B, Pons F, Martinez DE, Osaba MJ et al (1995) Factors involved in the loss of bone mineral density after renal transplantation. Transplant Proc 27:224–225 Torregrosa JV, Campistol JM, Montesinos M, Fenollosa B, Pons F, Martinez DE, Osaba MJ et al (1995) Factors involved in the loss of bone mineral density after renal transplantation. Transplant Proc 27:224–225
8.
go back to reference Aroldi A, Tarantino A, Montagnino G et al (1997) Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients. Transplant 63:380PubMed Aroldi A, Tarantino A, Montagnino G et al (1997) Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients. Transplant 63:380PubMed
9.
go back to reference Bardin T, Zingraff J, Kuntz D, Drüeke T (1986) Dialysis related amyloidosis. Nephrol Dial Transplant 1:151–154PubMed Bardin T, Zingraff J, Kuntz D, Drüeke T (1986) Dialysis related amyloidosis. Nephrol Dial Transplant 1:151–154PubMed
10.
go back to reference Jadoul M, Garbar C, Noel H, Sennesael J, Vanholder R, Bernaert P et al (1997) Histological prevalence of β2-microglobulin amyloidosis in hemodialysis: a prospective postmortem study. Kidney Int 51:1928–1932PubMed Jadoul M, Garbar C, Noel H, Sennesael J, Vanholder R, Bernaert P et al (1997) Histological prevalence of β2-microglobulin amyloidosis in hemodialysis: a prospective postmortem study. Kidney Int 51:1928–1932PubMed
11.
go back to reference Van Ypersele de Strihou C, Jadoul M, Malghem L, Maldague B, Jamart J (1991) Effect of hemodialysis membrane and patients' age on signs of dialysis related amyloidosis. Kidney Int 39:1012–1019PubMed Van Ypersele de Strihou C, Jadoul M, Malghem L, Maldague B, Jamart J (1991) Effect of hemodialysis membrane and patients' age on signs of dialysis related amyloidosis. Kidney Int 39:1012–1019PubMed
12.
go back to reference Kubo T, Fujioka M, Yamazoe S, Yashimura N, Oka T, Ushijima Y et al (1998) Relationship between steroid dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging. Transplant Proc 30:3039–3040CrossRefPubMed Kubo T, Fujioka M, Yamazoe S, Yashimura N, Oka T, Ushijima Y et al (1998) Relationship between steroid dosage and osteonecrosis of the femoral head after renal transplantation as measured by magnetic resonance imaging. Transplant Proc 30:3039–3040CrossRefPubMed
Metadata
Title
Joint pain and arthritis in renal transplant recipients and correlation with cyclosporine therapy
Authors
Hamide Kart-Köseoglu
A. E. Yücel
I. Isıklar
I. Türker
Z. Akçalı
M. Haberal
Publication date
01-07-2003
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 4/2003
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-002-0283-y

Other articles of this Issue 4/2003

Rheumatology International 4/2003 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.